Home › Categories › Corporate Reports› Piramal Pharma Limited Discloses Successful Closure Of US FDA Inspection

Piramal Pharma Limited Discloses Successful Closure Of US FDA Inspection.pdf

US-FDA-inspection_Bethlehem_closure_09.11.2023.pdf
Preview of Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection
🔗 Source: piramal.com
📊 Size: 275 KB
👤 Author: Management Trainee 3 Secretarial
⬇️ Downloads: 69

Summary

Piramal Pharma Limited announces the successful closure of a US Food and Drug Administration (US FDA) inspection at their manufacturing facility in Bethlehem, USA. This follows up on their previous communication dated September 28, 2023. The US FDA has issued an Establishment Inspection Report (EIR), indicating that the inspection process has been completed without any significant issues.

The company's registered office is located in Mumbai, India, and they have listings on both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). This disclosure is made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30.

Download File

Description

Piramal Pharma Limited announces the successful closure of a U.S. Food and Drug Administration (US FDA) inspection at its manufacturing facility in Bethlehem, USA, as per SEBI regulations. The inspection confirmed the facility's adherence to quality standards.

Technical Information

  • File Format: PDF
  • File Size: 275 KB
  • Pages: 1
  • Language: EN
  • Author: Management Trainee 3 Secretarial
  • Total Downloads: 69
  • Last Updated: 2 weeks ago

Document Overview

This PDF document about Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection.

Related Topics

If you're interested in Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection, you might also want to explore:

Piramal guidePiramal tutorialPharma guidePharma tutorialLimited guideLimited tutorialDiscloses guideDiscloses tutorialSuccessful guideSuccessful tutorialClosure guideClosure tutorialInspection guideInspection tutorial

Related Categories

Business & Finance
41204 documents
Education & Learning
22711 documents
Health & Wellness
8956 documents
Technology
4783 documents

Related Documents

Preview of Piramal Pharma Notice
PDF file

Piramal Pharma Notice

518 KBYogesh Navle (Ikya)EN16 pages
Piramal Pharma Limited is seeking approval from its members on certain resolutions through a postal ballot.
Download
Preview of Piramal Pharma Limited: Reclassification of Promoter Group to Public Shareholder
PDF file

Piramal Pharma Limited: Reclassification of Promoter Group to Public Shareholder

680 KBYogesh Navle (Ikya)EN2 pages
Piramal Pharma Limited receives a request to reclassify its status from 'Promoter Group' to 'Public Shareholder' under SEBI (Listing Obligations and...
Download
Preview of Outcome of Committee of Directors Meeting for Piramal Pharma Limited's Rights Issue
PDF file

Outcome of Committee of Directors Meeting for Piramal Pharma Limited's Rights Issue

240 KBCyril Amarchand MangaldasEN2 pages
Piramal Pharma Limited's Committee of Directors met on July 27, 2023, to discuss a rights issue, complying with SEBI Listing Regulations 30 and 42....
Download
Preview of Analyst Meeting Schedule
PDF file

Analyst Meeting Schedule

157 KBManagement Trainee 2 SecretarialEN1 page
Piramal Pharma Limited is informing BSE and NSE of its schedule of analyst/institutional investor meetings, with the first meeting being the...
Download
Preview of Download Issue PDF
PDF file

Download Issue PDF

6.95 MBEN52 pages
The article discusses the future of pharmacy chains, management of medications for seniors, and preparation for board of pharmacy inspections.
Download

Download Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection eBooks for free and learn more about Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection. These books contain exercises and tutorials to improve your practical skills, at all levels!

Not satisfied with this document? We have related documents to Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection, try searching with similar keywords: Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection, Outcome of Committee of Directors Meeting for Piramal Pharma Limited's Rights Issue, Piramal Pharma Limited: Reclassification of Promoter Group to Public Shareholder, Piramal Pharma Notice, zenith pharma listes des fichiers pdf zenith pharma zenith pharma, Discloses, 3m™ Closure System 2 Type 505 Cover 3m™ Closure System 2, Primary Closure Vs. Secondary Closure

You can download PDF versions of the user's guide, manuals and ebooks about Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection, you can also find and download for free A free online manual (notices) with beginner and intermediate, Downloads Documentation, You can download PDF files (or DOC and PPT) about Piramal Pharma Limited Discloses Successful Closure of US FDA Inspection for free, but please respect copyrighted ebooks.